Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

696 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Contribution of the subjective components of the disease activity score to the response to biologic treatment in rheumatoid arthritis.
Jurgens MS, Overman CL, Jacobs JW, Geenen R, Cuppen BV, Marijnissen AC, Bijlsma JW, Welsing PM, Lafeber FP, van Laar JM; Utrecht Arthritis Cohort Study Group. Jurgens MS, et al. Among authors: bijlsma jw. Arthritis Care Res (Hoboken). 2015 Jul;67(7):923-8. doi: 10.1002/acr.22532. Arthritis Care Res (Hoboken). 2015. PMID: 25504811 Free article. Clinical Trial.
Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial.
van Everdingen AA, Jacobs JW, Siewertsz Van Reesema DR, Bijlsma JW. van Everdingen AA, et al. Among authors: bijlsma jw. Ann Intern Med. 2002 Jan 1;136(1):1-12. doi: 10.7326/0003-4819-136-1-200201010-00006. Ann Intern Med. 2002. PMID: 11777359 Clinical Trial.
Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis.
Verzijl N, DeGroot J, Ben ZC, Brau-Benjamin O, Maroudas A, Bank RA, Mizrahi J, Schalkwijk CG, Thorpe SR, Baynes JW, Bijlsma JW, Lafeber FP, TeKoppele JM. Verzijl N, et al. Among authors: bijlsma jw. Arthritis Rheum. 2002 Jan;46(1):114-23. doi: 10.1002/1529-0131(200201)46:1<114::AID-ART10025>3.0.CO;2-P. Arthritis Rheum. 2002. PMID: 11822407 Free article.
Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells.
Taams LS, Vukmanovic-Stejic M, Smith J, Dunne PJ, Fletcher JM, Plunkett FJ, Ebeling SB, Lombardi G, Rustin MH, Bijlsma JW, Lafeber FP, Salmon M, Akbar AN. Taams LS, et al. Among authors: bijlsma jw. Eur J Immunol. 2002 Jun;32(6):1621-30. doi: 10.1002/1521-4141(200206)32:6<1621::AID-IMMU1621>3.0.CO;2-Q. Eur J Immunol. 2002. PMID: 12115645 Free article.
Clinical benefit of joint distraction in the treatment of severe osteoarthritis of the ankle: proof of concept in an open prospective study and in a randomized controlled study.
Marijnissen AC, Van Roermund PM, Van Melkebeek J, Schenk W, Verbout AJ, Bijlsma JW, Lafeber FP. Marijnissen AC, et al. Among authors: bijlsma jw. Arthritis Rheum. 2002 Nov;46(11):2893-902. doi: 10.1002/art.10612. Arthritis Rheum. 2002. PMID: 12428229 Free article. Clinical Trial.
696 results